Clinical Trials for B Cell Lymphoma

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma

NCT ID: NCT06742996

This clinical trial is studying a new combination treatment for adults with a type of cancer called mantle cell lymphoma (MCL) that has come back or has not responded to previous treatments. The re...

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

NCT ID: NCT07009002

This clinical trial is studying a new type of treatment called CD19-targeting CAR-T cell therapy for patients with a specific kind of blood cancer known as B-cell lymphoma that has not responded to...

SynKIR-310 for Relapsed/Refractory B-NHL

NCT ID: NCT06544265

The SynKIR-310 trial is a research study aimed at evaluating a new treatment called SynKIR-310 for adults with certain types of B-cell lymphoma that have not responded to previous therapies or have...

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

NCT ID: NCT06492304

This clinical trial is studying a new treatment called CTX131 for adults who have certain types of blood cancers, specifically relapsed or refractory T Cell Lymphoma, B Cell Lymphoma, and Acute Mye...

Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma

NCT ID: NCT06987916

This clinical trial is studying a new treatment called U01(ssCART-19) for patients with B-cell Non-Hodgkin's lymphoma, specifically those whose cancer has come back or did not respond to previous t...

A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors

NCT ID: NCT06976437

This clinical trial is studying a new treatment called RN1101, which uses special cells to target and attack certain types of blood cancers, specifically B-cell lymphomas and multiple myeloma that ...

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

NCT ID: NCT06662227

This clinical trial is studying a new treatment for patients with certain types of B-cell cancers, like B-cell lymphoma and leukemia, that have not responded to previous treatments. The trial is te...

Long-Term Follow-up Study

NCT ID: NCT05332054

Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma

NCT ID: NCT05412290

This clinical trial is investigating a new treatment called mosunetuzumab for patients with aggressive B cell lymphomas, which are types of cancer affecting the lymphatic system. The study aims to ...

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT ID: NCT06131801

This clinical trial is studying how well venetoclax, a medication used to treat certain types of blood cancers like leukemia and lymphoma, works when the tablets are crushed and dissolved in liquid...

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

NCT ID: NCT04637763

The ANTLER clinical trial is studying a new treatment called CB010A for adults with a type of blood cancer known as relapsed or refractory B-cell non-Hodgkin lymphoma. This means the lymphoma has e...

A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma

NCT ID: NCT06213311

This clinical trial is looking to see if a new combination treatment, made up of two medications called axicabtagene ciloleucel (axi-cel) and glofitamab, can help patients with a type of blood canc...

Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma

NCT ID: NCT06485076

This clinical trial is looking at the benefits of early palliative care for patients with multiple myeloma and aggressive B cell lymphoma, which are types of blood cancers. Palliative care focuses ...

Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis

NCT ID: NCT06058858

This clinical trial is studying how often a virus called Cytomegalovirus (CMV) reactivates in patients who receive a special type of treatment known as CAR-T cell therapy for acute leukemia or B-ce...

Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma

NCT ID: NCT06415708

This clinical trial is studying a treatment for patients with newly diagnosed mature B-cell lymphoma, which includes types like follicular lymphoma and Waldenström macroglobulinemia. The trial is t...

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

NCT ID: NCT06180174

This clinical trial is looking at a new treatment called MC-1-50 for patients with relapsed or refractory B-cell non-Hodgkin lymphoma, a type of blood cancer that has not responded to previous trea...

A Study of SHR-A1912 for Injection in Patients With B Cell Lymphomas

NCT ID: NCT05113069

ThisCART19A for B-NHL Relapsed After Auto-CAR T

NCT ID: NCT05691153

This clinical trial is studying a new treatment called ThisCART19A for patients who have B-cell non-Hodgkin lymphoma that has come back after being treated with another CAR T-cell therapy. The goal...

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

NCT ID: NCT05415098

This clinical trial is studying a new medication called APG-5918 to see how safe it is and how well it works for patients with advanced solid tumors or certain types of lymphomas, including nasopha...

A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia

NCT ID: NCT03383952

This clinical trial is studying a new type of treatment called CD19 targeted CAR-T therapy for patients with certain types of blood cancers, specifically B Cell Leukemia and B Cell Lymphoma. The go...